Technical420 Site Search

GW Pharmaceuticals plc (GWPH) continues to lead the medical cannabis movement…This morning, the company reported its second positive Stage 3 Clinical trial for its Epidiolex product for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS).This trial follows the announcement in June 2016 of positive results in the first pivotal…

 Cannabis stocks continue to rally and with the presidential election right around the corner, we do not expect this trend to end anytime soon.That being said, we do not recommend diving head first into the industry as the market is nothing like it was in early 2014 when you could…

Signal Bay, Inc. (SGBY) filed its quarterly financial results for the period that ended on June 30th. Signal Bay consists of three business units and it provides advisory, management and analytical testing services to the legal cannabis industry. Business Units  Signal Bay Research provides industry research, business and market intelligence, and…

The global economy is entering unchartered territory and several of the world’s most successful investors painted a gloomy picture of the United States economy and stock market at the Delivering Alpha conference yesterday.Although these investors shared a common outlook and perspective, they overlooked a number of bright spots and opportunities within…

The cannabis sector came down from its highs on Friday as global markets plunged on heightened concerns over higher interest rates.The Nasdaq was the hardest hit and the exchange fell more than 2.5%, while the Dow and S&P 500 dropped more than 2% each.What to Expect Today?This market is poised…

GW Pharmaceuticals (GWPH) shares jumped more than 20% after it reported that it was working with Morgan Stanley after other drug makers approached it to express interest in an acquisition, according to people familiar with the matter.GW is one of the leaders in the cannabis industry. The British biopharmaceutical company…

“You can't have your cake and eat it too”We heard this expression used recently when trying to describe how hard it is to invest in a company that has a large dividend and significant growth potential.Although this is typically the case with public companies; it is not the case in the cannabis…